Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report

References

• Rogers DP, Shramko JK. Therapeutic options in the treatment of clozapine-induced sialorrhea. Pharmacotherapy. 2000;20(9):1092–1095, Review. doi: 10.1592/phco.20.13.1092.35036
   Web of Science ®Google Scholar
• Solismaa A, Kampman O, Seppala N, et al. Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment. Hum Psychopharmacol Clin Exp. 2014;29(4):336–341. doi: 10.1002/hup.2408
   Web of Science ®Google Scholar
• Rabinowitz T, Frankenburg FR, Centorrino F, et al. The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry. 1996;40(11):1132–1134. doi: 10.1016/S0006-3223(96)89255-9
   PubMed Web of Science ®Google Scholar
• Gurrera RJ, Parlee AC, Perry NL. Aspiration pneumonia: an underappreciated risk of clozapine treatment. J Clin Psychopharmacol. 2016;36(2):174–176. doi: 10.1097/JCP.0000000000000458
   PubMed Web of Science ®Google Scholar
• Liang CS, Ho PS, Shen LJ, et al. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Schizophr Res. 2010;119(1–3):138–144. doi: 10.1016/j.schres.2010.02.1060
   PubMed Web of Science ®Google Scholar
• Kulkarni RR. Low-dose amisulpride for debilitating clozapine-induced sialorrhea: case series and review of literature. Indian J Psychol Med. 2015;37(4):446–448. doi: 10.4103/0253-7176.168592
   Google Scholar
• Takeuchi I, Suzuki T, Kishi T, et al. Effect of scopolamine butylbromide on clozapine-induced hypersalivation in schizophrenic patients: a case series. Clin Psychopharmacol Neurosci. 2015;13(1):109–112. doi: 10.9758/cpn.2015.13.1.109
   Web of Science ®Google Scholar
• Sinha S, Simlai J, Praharaj SK. Very low dose amitriptyline for clozapine-associated sialorrhea. Curr Drug Saf. 2016;11(3):262–263. doi: 10.2174/1574886311666160426130252
   PubMed Web of Science ®Google Scholar
• Kreinin A, Miodownik C, Mirkin V, et al. Double-blind, randomized, placebo-controlled trial of metoclopramide for hypersalivation associated with clozapine. J Clin Psychopharmacol. 2016;36(3):200–205. doi: 10.1097/JCP.0000000000000493
   Web of Science ®Google Scholar
• Santana TE, Capurso NA, Ranganathan M, et al. Sublingual atropine in the treatment of clozapine-induced sialorrhea. Schizophr Res. 2017;182:144–145. doi: 10.1016/j.schres.2016.10.039
   Web of Science ®Google Scholar
• Antonello C, Tessier P. Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. J Psychiatry Neurosci. 1999;24(3):250.
   Web of Science ®Google Scholar
• Comley C, Galletly C, Ash D. Use of atropine eye drops for clozapine induced hypersalivation. Aust N Z J Psychiatry. 2000;34(6):1033–1034. doi: 10.1080/000486700285
   Web of Science ®Google Scholar
• Mustafa FA, Khan A, Burke J, et al. Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea. Afr J Psychiatry. 2013;16(4):242.
   Google Scholar
• Sharma A, Ramaswamy S, Dahl E, et al. Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea. Ann Pharmacother. 2004;38(9):1538. doi: 10.1345/aph.1E077
   PubMed Web of Science ®Google Scholar
• Leung JG, Schak KM. Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea. Schizophr Res. 2017;185:202–203. doi: 10.1016/j.schres.2016.12.028
   Web of Science ®Google Scholar
• Lazareno S, Buckley NJ, Roberts FF. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart and NG108-15 cells. Mol Pharmacol. 1990;38(6):805–815.
   Web of Science ®Google Scholar
• Lloret SP, Nano G, Carrosella A, et al. A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson’s disease patients. J Neurol Sci. 2011;310(1–2):248–250. doi: 10.1016/j.jns.2011.05.021
   PubMed Web of Science ®Google Scholar
• Schmidt KS, Hacker DV, Kass PH, et al. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats. Vet Ophthalmol. 2006;9(2):137–139. doi: 10.1111/j.1463-5224.2006.00447.x
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of psychiatric disorders. 5th ed. Washington (DC): American Psychiatric Association; 2013.
   Google Scholar
• Spivak B, Adlersberg S, Rosen L, et al. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol. 1997;12(4):213–215. doi: 10.1097/00004850-199707000-00005
   PubMed Web of Science ®Google Scholar
• Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989;1(7):49–58.
   Google Scholar
• Andreasen N. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984.
   Google Scholar
• Erkoç Ş, Arkonaç O, Ataklı C. The reliability and validity of scale for the assessment of the negative symptoms. Düşünen Adam. 1991;4:16–19 [Turkish].
   Google Scholar
• Erkoç Ş, Arkonaç O, Ataklı C. The reliability and validity of scale for the assessment of the positive symptoms. Düşünen Adam. 1991;4:20–24 [Turkish].
   Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual Framework and Item Selection. Med Care. 1992;30(6):473–483.
   Google Scholar
• Koçyiğit H, Aydemir Ö, Ölmez N, et al. Kısa Form-36 (KF-36)’nın türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi. 1999;12(1):102–106 [Turkish].
   Google Scholar
• Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU Side Effect Rating Scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334(76):1–100. doi: 10.1111/j.1600-0447.1987.tb10566.x
   Google Scholar
• Godoy T, Riva A, Ekström J. Atypical antipsychotics – effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea. Oral Dis. 2012;18(7):680–691. doi: 10.1111/j.1601-0825.2012.01926.x
   Web of Science ®Google Scholar
• Sockalingam S, Shammi C, Remington G. Clozapine-induced hypersalivation: a review of treatment strategies. Can J Psychiatry. 2007;52(6):377–384. doi: 10.1177/070674370705200607
   Web of Science ®Google Scholar
• Vuori ML, Kaila T, Iisalo E, et al. Systemic absorption and anticholinergic activity of topically applied tropicamide. J Ocul Pharmacol. 1994;10:431–437. doi: 10.1089/jop.1994.10.431
   PubMedGoogle Scholar
• Spagnolo PA, Badiani A, Nencini P. Polydrug abuse by intravenous use of heroin and tropicamide-containing eyedrops. Clin Neuropharmacol. 2013;36(3):100–101. doi: 10.1097/WNF.0b013e31828da20e
   PubMed Web of Science ®Google Scholar